KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-1.1x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -16.78% |
| 2024 | 7.34% |
| 2023 | 14.41% |
| 2022 | 69.95% |
| 2021 | 2.72% |
| 2020 | 14.77% |
| 2019 | 92.03% |
| 2018 | 43.98% |
| 2017 | -13.61% |
| 2016 | 76.96% |